General Federal Contracts — September 22, 2026

QTC Medical Services, a Leidos subsidiary, secured a $240.6 million firm-fixed-price delivery order from the VA for physician-based medical evaluations. The contract is fully funded with $233.6 million already outlayed, signaling near-term revenue certainty but no upside from options or extensions.

Leidos/QTC's revenue is heavily concentrated in this single VA contract with no options or follow-on task orders identified. The contract ends September 30, 2024, creating a potential revenue gap for the subsidiary.

The contract is fully outlayed (97% utilization), suggesting no additional funding headroom. Any future VA budget cuts or CR-driven delays could impact follow-on awards.

The VA's sustained spending on medical evaluations ($240M+ annually) indicates a stable healthcare services budget. Leidos/QTC could capture follow-on awards or expand into other VA health service lines.

The VA awarded a $240.6M firm-fixed-price contract for medical evaluations, reflecting consistent demand for outsourced physician-based screening services. This theme supports contractors with VA health service exposure.

{"entity" => "Leidos Holdings (LDOS)", "reason" => "QTC subsidiary's $240.6M VA contract ends Sep 2024 with no options; revenue cliff risk for FY25.", "trigger" => "VA re-compete announcement for medical evaluation services or QTC earnings call discussing follow-on work"}

{"entity" => "Department of Veterans Affairs", "reason" => "VA's medical evaluation budget trend determines future contract opportunities for Leidos/QTC and competitors.", "trigger" => "FY25 VA budget proposal or CR passage affecting discretionary health spending"}